TECHNETIUM TC-99M MEDRONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Technetium Tc-99m Medronate, and what generic alternatives are available?
Technetium Tc-99m Medronate is a drug marketed by Cardinal Health 414 and is included in one NDA.
The generic ingredient in TECHNETIUM TC-99M MEDRONATE is technetium tc-99m medronate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m medronate kit profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Technetium Tc-99m Medronate
A generic version of TECHNETIUM TC-99M MEDRONATE was approved as technetium tc-99m medronate kit by CARDINAL HEALTH 414 on December 31st, 1969.
Summary for TECHNETIUM TC-99M MEDRONATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TECHNETIUM TC-99M MEDRONATE at DailyMed |
Recent Clinical Trials for TECHNETIUM TC-99M MEDRONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Utah | Phase 2 |
University of Manitoba | Phase 3 |
Winnipeg Regional Health Authority | Phase 3 |
US Patents and Regulatory Information for TECHNETIUM TC-99M MEDRONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardinal Health 414 | TECHNETIUM TC-99M MEDRONATE KIT | technetium tc-99m medronate kit | INJECTABLE;INJECTION | 018107-001 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |